Terns Pharmaceuticals Inc (NASDAQ:TERN)’s traded shares stood at 0.87 million during the last session, with the company’s beta value hitting -0.45. At the close of
In last trading session, Terns Pharmaceuticals Inc (NASDAQ:TERN) saw 1.04 million shares changing hands with its beta currently measuring -0.58. Company’s recent per share price
During the last session, Terns Pharmaceuticals Inc (NASDAQ:TERN)’s traded shares were 1.78 million, with the beta value of the company hitting -0.64. At the end
Terns Pharmaceuticals Inc (NASDAQ:TERN)’s traded shares stood at 1.23 million during the last session, with the company’s beta value hitting -0.66. At the close of
Terns Pharmaceuticals Inc (NASDAQ:TERN) has a beta value of -0.62 and has seen 0.93 million shares traded in the last trading session. The company, currently
In the last trading session, 1.3 million shares of the Terns Pharmaceuticals Inc (NASDAQ:TERN) were traded, and its beta was -0.62. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
